摘要
目的:分析不同入路半髋关节置换术治疗高龄股骨颈骨折患者的效果。方法:分析2024年9月—2025年8月于化州市人民医院接受半髋关节置换术治疗的60例高龄股骨颈骨折患者的临床资料,根据手术入路方式将患者分为对照组(30例,采用改良Hardinge入路)和观察组(30例,采用OCM入路)。比较两组临床疗效。结果:与对照组相比,观察组切口长度更短(P<0.001),下床活动时间、住院时间更短(P<0.001);两组手术时间无统计学差异(P>0.05)。术后12、24、48 h,观察组视觉模拟评分法评分低于对照组(P<0.05)。观察组并发症发生率低于对照组(P=0.038)。术后4周,观察组疼痛、功能、畸形、活动度评分高于对照组(P<0.05)。结论:OCM入路半髋关节置换术治疗高龄股骨颈骨折的效果优于改良Hardinge入路,可以优化手术相关指标,减轻疼痛程度,减少并发症,提高髋关节功能。
Objective:To analyze the effects of different approaches of hemiarthroplasty in the treatment of femoral neck fractures in the elderly patients.Methods:A analysis was conducted on the clinical data of 60 elderly patients with femoral neck fractures who underwent hemiarthroplasty at People's Hospital of Huazhou from September 2024 to August 2025.Based on the surgical approaches,the patients were divided into control group(30 patients,using the modified Hardinge approach)and observation group(30 patients,using the OCM approach).The clinical efficacy of the two groups was compared.Results:Compared with the control group,the observation group had shorter incision length(P<0.001),and shorter ambulation time and length of hospital stay(P<0.001).There was no statistically significant difference in operation time between the two groups(P>0.05).At 12 h,24 h and 48 h after surgery,the visual analogue scale scores in the observation group were lower than those in the control group(P<0.05).The incidence of complications in the observation group was lower than that in the control group(P=0.038).At 4 weeks after surgery,the scores of pain,function,deformity and activity in the observation group were higher than those in the control group(P<0.05).Conclusion:Hemiarthroplasty via OCM approach is superior to that via the modified Hardinge approach in the treatment of femoral neck fractures in the elderly,and can optimize the surgery related indicators,relieve the degree of pain,reduce complications,and improve hip joint function.
作者
魏朝虎
Wei Chaohu(Department of Orthopedics,People's Hospital of Huazhou,Huazhou 525199,Guangdong Province,China)
出处
《中外医药研究》
2025年第31期78-80,共3页
JOURNAL OF CHINESE AND FOREIGN MEDICINE AND PHARMACY RESEARCH
